Speaker

Filipe Pereira is a Professor in Molecular Medicine at the Faculty of Medicine of Lund University in Sweden. Dr. Pereira is recognized for his work at the interface of cellular reprogramming and immunology and for fostering development of reprogramming-based immunotherapies. He pioneered the induction of dendritic cells from fibroblasts or cancer cells. Dr. Pereira co-founded Asgard Therapeutics, which received investment from leading VCs to translate in vivo dendritic cell reprogramming to benefit cancer patients. He received several prestigious awards including 3 ERC Grants, Novo Nordisk Distinguished Innovator, Swedish Fernström Prize and a medal of merit from his hometown in Portugal.

Homepage: Pereiralab.com
LinkedIn: www.linkedin.com/in/carlosfilipepereira
Twitter: @CellReproLab

« Go Back